1. Wise, R., Andrews, J. M., Edwards, L. J. In vitro activity of Bay 9867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrob. Agents Chemother. 23 (1983) 569–574.
2. Fass, R. J. In vitro activity of ciprofloxacin (Bay 9867). Antimicrob. Agents Chemother. 24 (1983) 568–573.
3. Schacht, P., Deck, K., Arieri, G., Ryoki, T. Overview of international clinical studies of ciprofloxacin, with special reference to safety. In:Neu, H. C., Weuta, H. (eds.): 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Medica, Amsterdam, 1986, pp. 435–445.
4. Limson, B. M. Efficacy and safety of ciprofloxacin in uncomplicated typhoid fever. In:Neu, H. C., Weuta, H. (eds.): 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Medica, Amsterdam, 1986, pp. 362–364.
5. Ramirez, C. A., Bran, J. L., Mejica, C. R., Garcia, J. F. Clinical efficacy of ciprofloxacin in typhoid fever. In:Neu, H. C., Weuta, H. (eds.): 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Medica, Amsterdam, 1986, pp. 365–369.